Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dylan Martini, M.D.

Concepts (132)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell19202331432.330 Why?
Kidney Neoplasms19202342622.090 Why?
Sezary Syndrome22022760.990 Why?
Anilides320214080.940 Why?
Mycosis Fungoides220221630.930 Why?
Immunotherapy10202244450.800 Why?
Mucositis120211010.750 Why?
Carcinoma, Transitional Cell320238080.750 Why?
Sarcopenia420223680.540 Why?
Pyridines3202128250.510 Why?
Urinary Bladder Neoplasms3202322450.500 Why?
Skin Neoplasms4202256860.470 Why?
Antineoplastic Combined Chemotherapy Protocols62020115240.450 Why?
Adiposity2202018070.450 Why?
Interleukin-21201919040.410 Why?
Neoplasms72022216830.370 Why?
Interferon-gamma1201932060.360 Why?
Graft vs Host Disease1202229570.350 Why?
Lymphoma, T-Cell, Cutaneous220222070.350 Why?
Hematopoietic Stem Cell Transplantation2202354420.310 Why?
Protein Kinase Inhibitors2202155350.310 Why?
Retrospective Studies252023774490.290 Why?
Georgia220201860.220 Why?
Hypoalbuminemia12022870.200 Why?
Hypertension1202184800.200 Why?
Methemoglobinemia12021440.190 Why?
Immune System Diseases120232620.190 Why?
Acetamides120222490.190 Why?
Obesity22020127450.190 Why?
Prognosis102022290630.190 Why?
Antibodies, Monoclonal1201792740.180 Why?
Liver Neoplasms3202142530.180 Why?
Leukocyte Count2202115880.180 Why?
Genes, APC120201590.180 Why?
Lymphohistiocytosis, Hemophagocytic120232600.180 Why?
Adenomatous Polyposis Coli Protein120201880.170 Why?
Neoplasm Staging52022110310.170 Why?
Melanoma1201755100.170 Why?
Male2420223501180.160 Why?
Kaplan-Meier Estimate2202165380.160 Why?
Adenomatous Polyposis Coli120202240.160 Why?
Humans3920237443430.160 Why?
Antineoplastic Agents12021136950.150 Why?
Nitriles120229560.150 Why?
Steroids120229300.150 Why?
Urologic Neoplasms120203180.130 Why?
Proportional Hazards Models22021123540.130 Why?
Bacteremia120229620.130 Why?
Body Composition2202124010.130 Why?
Female2020213801940.130 Why?
United States Food and Drug Administration1202215840.120 Why?
Aged1520221632800.120 Why?
Survival Analysis42019102520.120 Why?
Middle Aged1620222133830.110 Why?
Treatment Outcome92020631140.110 Why?
Lymphocyte Count320217930.110 Why?
Neutrophils3202337190.110 Why?
Adipose Tissue2202032790.100 Why?
Neoplasm Metastasis2202148510.100 Why?
Risk Factors52021722900.100 Why?
Mutation, Missense1202025640.100 Why?
Acute Kidney Injury1202319720.100 Why?
Autoimmune Diseases1202221330.090 Why?
Lymphocytes1201826170.090 Why?
Molecular Targeted Therapy2201827270.090 Why?
Carcinoma, Hepatocellular1202122140.080 Why?
Clinical Trials, Phase I as Topic220193230.080 Why?
Nephrectomy2202210500.070 Why?
Body Mass Index22021127200.060 Why?
Adult1020232140550.060 Why?
Adenocarcinoma1202263640.060 Why?
Risk Assessment22022233380.050 Why?
Young Adult52020564300.050 Why?
Genes, T-Cell Receptor12021290.050 Why?
Bilirubin120234250.050 Why?
Receptors, Interleukin-2120235730.050 Why?
HLA-DR Antigens120236450.050 Why?
Renal Replacement Therapy120232570.050 Why?
Anti-Bacterial Agents1201971810.050 Why?
Glasgow Outcome Scale120211090.050 Why?
Disease Progression12017132840.050 Why?
Ferritins120235900.050 Why?
Albumins120225690.040 Why?
Prostatic Neoplasms12022111240.040 Why?
RNA Splice Sites120202090.040 Why?
Databases, Protein120203830.040 Why?
Retreatment120206100.040 Why?
Eosinophils120239550.040 Why?
Cohort Studies42022405610.040 Why?
Aged, 80 and over52020577760.040 Why?
Patients120239000.040 Why?
Lymph Node Excision1202212610.040 Why?
Platelet Count120187810.030 Why?
Sequence Alignment1202022560.030 Why?
Protein Isoforms1202017300.030 Why?
Prospective Studies12019532880.030 Why?
T-Lymphocyte Subsets1202318380.030 Why?
Lymphatic Metastasis1202229240.030 Why?
United States12022698720.030 Why?
Exons1202024370.030 Why?
Staphylococcus aureus1202214510.030 Why?
Enhancer Elements, Genetic1202013410.030 Why?
Phylogeny1202028030.030 Why?
Chromosomal Proteins, Non-Histone120187360.030 Why?
Lymphocyte Activation1202355240.030 Why?
Evolution, Molecular1202019400.020 Why?
Lymph Nodes1202234740.020 Why?
Critical Illness1202326700.020 Why?
Flow Cytometry1202159740.020 Why?
Inflammation22021106380.020 Why?
Angiogenesis Inhibitors1202020380.020 Why?
Vascular Endothelial Growth Factor A1202135080.020 Why?
CD8-Positive T-Lymphocytes1202344790.020 Why?
Amino Acid Sequence12020138150.020 Why?
Computational Biology1202035210.020 Why?
Boston1202093130.020 Why?
Computer Simulation1202061960.020 Why?
Survival Rate12020127880.020 Why?
Muscle, Skeletal1202049310.020 Why?
Genetic Variation1202065440.020 Why?
Logistic Models12018134080.010 Why?
Genomics1201857200.010 Why?
Gene Expression Profiling1201894380.010 Why?
Cell Line, Tumor12018166890.010 Why?
Quality of Life12022128040.010 Why?
Algorithms12020138810.010 Why?
Time Factors12020400750.010 Why?
Follow-Up Studies12020390500.010 Why?
Transcription Factors12018122080.010 Why?
Tomography, X-Ray Computed12020201290.010 Why?
Magnetic Resonance Imaging12020354210.010 Why?
Mutation12018297860.010 Why?
Martini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (132)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.